The collaboration will focus on the radiation oncology research to advance treatment technology.
With the signing of collaboration agreement with the University of Heidelberg in March 2012, the company will now be able to advance the field of radiation oncology with two luminary research institutions.
Accuray president and chief executive officer Euan Thomson said, "These agreements with DKFZ and University of Heidelberg, focused on both the CyberKnife and TomoTherapy technologies, enable us to continue the important collaborative research in radiation oncology that has been underway for nearly a decade."